医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NTT to Donate US$3M for Pandemic Relief to India

2021年05月19日 PM03:00
このエントリーをはてなブックマークに追加


 

TOKYO

NTT (TOKYO:9432) announces today plans to donate US$3 million to support the humanitarian tragedy facing the people of India. In addition to this, the NTT companies are contributing support and services for their employees to help cope with this challenging situation.

India has NTT’s largest country employee base outside of Japan, with 30,000 NTT employees, playing a critical role in supporting our clients and our business worldwide. The pandemic’s devastating impact on India and its people deeply saddens all of us.

NTT sincerely hopes that this donation and the other relief support provided by NTT companies will help provide some necessary resources for those suffering from the impact of this virus. Our thoughts and prayers are with our colleagues, clients, their families and all of India’s society.

We are proud of the NTT family of companies for coming together and offering this critical help during this difficult time. As part of our history and values, we always respond to the needs of people, communities and society through our actions and business operations.

About NTT

NTT believes in resolving social issues through our business operations by applying technology for good. We help clients accelerate growth and innovate for current and new business models. Our services include digital business consulting, technology and managed services for cybersecurity, applications, workplace, cloud, data center and networks, all supported by our deep industry expertise and innovation. As a top 5 global technology and business solutions provider, our diverse teams operate in 80+ countries and regions and deliver services to over 190 of them. We serve over 80% of Fortune Global 100 companies and thousands of other clients and communities around the world. For more information on NTT, visit www.global.ntt.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518006238/en/

CONTACT

Media Contact

Yuzo Aramaki

PR Office, NTT Corporation

TEL: +81-3-6838-5100 MOB: +81-90-1609-8041

Email: yuzo.aramaki@ntt.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Medidata宣布快速扩展其传感器云网络,再添10家卫生技术创新组织
  • ウォルグリーン・ブーツ・アライアンスが戦略的見直しを完了し、好業績のブーツ事業の所有権を保持することを決定
  • OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of OLX10212 in Phase 1 Clinical Trial
  • DEXLEVO Strengthens Global Reputation of GOURI at IMCAS, the World’s Largest Beauty Anti-Aging Society
  • Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation